tiprankstipranks
Trending News
More News >
Kyntra Bio (KYNB)
NASDAQ:KYNB
US Market

Kyntra Bio (KYNB) Income Statement

Compare
1,064 Followers

Kyntra Bio Income Statement

Last quarter (Q4 2025), Kyntra Bio's total revenue was $1.28M, a decrease of -101.04% from the same quarter last year. In Q4, Kyntra Bio's net income was $-14.22M. See Kyntra Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 6.44M$ 29.62M$ 46.80M$ 140.73M$ 235.31M
Gross Profit
$ 0.00$ 14.06M$ 42.84M$ 120.45M$ -213.88M
Operating Expenses
$ 51.23M$ 164.48M$ 365.56M$ 421.48M$ 74.65M
Depreciation and Amortization
$ 748.00K$ 2.69M$ 9.93M$ 10.60M$ 14.81M
EBITDA
$ -45.90M$ -142.43M$ -305.20M$ -282.82M$ -333.72M
Operating Income
$ -45.90M$ -150.42M$ -322.72M$ -301.02M$ -288.53M
Other Income/Expenses
$ -12.40M$ -2.95M$ -501.00K$ 7.73M$ -1.15M
Pretax Income
$ -58.29M$ -153.37M$ -323.22M$ -293.30M$ -289.68M
Net Income
$ 183.45M$ -47.58M$ -284.23M$ -293.65M$ -290.02M
Per Share Metrics
Basic EPS
$ 45.37$ -0.48$ -2.92$ -3.15$ -3.15
Diluted EPS
$ 45.37$ -0.48$ -2.92$ -3.15$ -3.15
Weighted Average Shares Outstanding
4.04M 100.04M 97.30M 93.58M 92.35M
Weighted Average Shares Outstanding (Diluted)
4.04M 100.04M 97.30M 93.58M 92.35M
Currency in USD

Kyntra Bio Earnings and Revenue History